Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study

Yangyang Cen, Xi Chen, Yuning Shen, +8

Clinical Microbiology and Infection

Virus EpidemiologyDisease ProgressionDisease Risk AssessmentCovid-19 PandemicClinical Epidemiology +10

Post-infection cognitive impairments in a cohort of elderly patients with COVID-19

Yuhui Liu, Ye‐Ran Wang, Qinghua Wang, +16

Molecular Neurodegeneration

Cytosolic cleaved <scp>PINK</scp> 1 represses <scp>P</scp> arkin translocation to mitochondria and mitophagy

Maja A. Fedorowicz, Rosa L. A. de Vries‐Schneider, Cornelia Rüb, +7

EMBO Reports

MitophagyMitochondrial BiogenesisMitochondrial DynamicNatural SciencesAutophagy +8

Basic Helix-Loop-Helix Proteins Bind to <i>TrkB</i> and <i>p21^Cip1</i> Promoters Linking Differentiation and Cell Cycle Arrest in Neuroblastoma Cells

Yuhui Liu, Mario Encinas, Joan X. Comella, +2

Molecular and Cellular Biology

Diagnostic accuracy of plasma p‐tau217/Aβ42 for Alzheimer's disease in clinical and community cohorts

Jun Wang, Shan Huang, Guoyu Lan, +23

Alzheimer s & Dementia

Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer’s disease

Yuhui Liu, Jun Wang, Qiao‐Xin Li, +10

Science Advances

Rejuvenation of peripheral immune cells attenuates Alzheimer’s disease-like pathologies and behavioral deficits in a mouse model

Pu‐Yang Sun, Jie Liu, Jian-Ni Hu, +15

Science Advances

Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.

Yaoling Luo, Guoping Ou, Peidong Chi, +3

PubMed

Inhibiting α1‐adrenergic receptor signaling pathway ameliorates <scp>AD</scp>‐type pathologies and behavioral deficits in <scp>APPswe</scp>/<scp>PS1</scp> mouse model

Zhongyuan Yu, Xu Yi, Ye‐Ran Wang, +7

Journal of Neurochemistry

Neurochemical BiomarkersSynaptic SignalingSocial SciencesNeuroinflammationMolecular Pharmacology +25

Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)

Jie Liu, Heleen van Beusekom, Xian‐Le Bu, +26

Neuroprotection/Neuroprotection (Chichester, England. Print)